Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | JAAD International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328724000166 |
| _version_ | 1797237949189849088 |
|---|---|
| author | Richard G. Langley, MD Chiranjeev Sanyal, PhD Aaron Situ, MSc Sarah Alulis, MSc Fareen Hassan, MSc Steve Peterson, MPH Rachel E. Teneralli, PhD Jennifer Lee, MBA Barkha P. Patel, PhD Tim Disher, PhD |
| author_facet | Richard G. Langley, MD Chiranjeev Sanyal, PhD Aaron Situ, MSc Sarah Alulis, MSc Fareen Hassan, MSc Steve Peterson, MPH Rachel E. Teneralli, PhD Jennifer Lee, MBA Barkha P. Patel, PhD Tim Disher, PhD |
| author_sort | Richard G. Langley, MD |
| collection | DOAJ |
| first_indexed | 2024-04-24T17:27:52Z |
| format | Article |
| id | doaj.art-22186959faf64799ac3671ec41d4d380 |
| institution | Directory Open Access Journal |
| issn | 2666-3287 |
| language | English |
| last_indexed | 2024-04-24T17:27:52Z |
| publishDate | 2024-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD International |
| spelling | doaj.art-22186959faf64799ac3671ec41d4d3802024-03-28T06:38:43ZengElsevierJAAD International2666-32872024-06-0115165167Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40Richard G. Langley, MD0Chiranjeev Sanyal, PhD1Aaron Situ, MSc2Sarah Alulis, MSc3Fareen Hassan, MSc4Steve Peterson, MPH5Rachel E. Teneralli, PhD6Jennifer Lee, MBA7Barkha P. Patel, PhD8Tim Disher, PhD9Division of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Community Health and Epidemiology, College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada; CRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, CanadaCRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, Canada; Tigermed BDM, Somerset, New JerseyJanssen-Cilag A/S, Birkerød, DenmarkJanssen-Cilag Ltd, High Wycombe, United KingdomJanssen Immunology Global Commercial Strategy Organization, Horsham, PennsylvaniaJanssen Immunology Global Commercial Strategy Organization, Horsham, PennsylvaniaJanssen-Cilag A/S, Birkerød, DenmarkCRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, CanadaCRG-EVERSANA, Value and Evidence Services, Burlington, Ontario, Canada; Correspondence to: Tim Disher, RN, PhD, EVERSANA, 3228 S Service Rd, Burlington, ON, L7N 3H8, Canadahttp://www.sciencedirect.com/science/article/pii/S2666328724000166change from baselineguselkumabindirect treatment comparisonsmatching-adjusted indirect comparisonrisankizumabPASI |
| spellingShingle | Richard G. Langley, MD Chiranjeev Sanyal, PhD Aaron Situ, MSc Sarah Alulis, MSc Fareen Hassan, MSc Steve Peterson, MPH Rachel E. Teneralli, PhD Jennifer Lee, MBA Barkha P. Patel, PhD Tim Disher, PhD Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40 JAAD International change from baseline guselkumab indirect treatment comparisons matching-adjusted indirect comparison risankizumab PASI |
| title | Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40 |
| title_full | Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40 |
| title_fullStr | Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40 |
| title_full_unstemmed | Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40 |
| title_short | Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40 |
| title_sort | matching adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate to severe plaque psoriasis change in baseline psoriasis area and severity index from week 4 to 40 |
| topic | change from baseline guselkumab indirect treatment comparisons matching-adjusted indirect comparison risankizumab PASI |
| url | http://www.sciencedirect.com/science/article/pii/S2666328724000166 |
| work_keys_str_mv | AT richardglangleymd matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT chiranjeevsanyalphd matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT aaronsitumsc matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT sarahalulismsc matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT fareenhassanmsc matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT stevepetersonmph matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT racheleteneralliphd matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT jenniferleemba matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT barkhappatelphd matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 AT timdisherphd matchingadjustedindirectcomparisonofguselkumabversusrisankizumabinpatientswithmoderatetosevereplaquepsoriasischangeinbaselinepsoriasisareaandseverityindexfromweek4to40 |